Arkolith/Insider Trading/ALT/Form 4

Garg Vipin K

President and CEO, DirectorAltimmune, Inc. (ALT) · full profile →Form 4 · filed Feb 3, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
10
7 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 2, 2025Option exercise(M)19K—$0363K
Feb 2, 2025Tax withholding(F)8K$6.64$55K355K
Feb 1, 2025Option exercise(M)17K—$0352K
Feb 1, 2025Tax withholding(F)7K$6.64$48K344K
Jan 31, 2025Grant(A)4K$5.18$21K335K
Jan 30, 2025Option exercise(M)27K—$0343K
Jan 30, 2025Tax withholding(F)12K$7.00$82K331K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 2, 2025Option exercise(M)19K—$019K
Feb 1, 2025Option exercise(M)17K—$00
Jan 30, 2025Option exercise(M)27K—$054K

Transaction Codes

M
Option exercise / conversion
F
Shares withheld for taxes
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-25-008773) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML